Creative Media & Community Trust to Report Q4 2025 Earnings on March 9, 2026
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy CMCT?
Source: Newsfilter
- Earnings Report Schedule: Creative Media & Community Trust (CMCT) will announce its Q4 2025 earnings results on March 9, 2026, before the market opens, providing insights into the company's financial performance and future outlook.
- Conference Call Details: A conference call is scheduled for 5:00 PM Eastern Time on the same day, hosted by CEO David Thompson and other executives, aimed at discussing financial results and addressing investor questions to enhance transparency.
- Investor Participation Methods: Investors can register and test their connection via the 'Investors' tab on the company website or call in using domestic and international numbers, ensuring broad investor engagement and effective information dissemination.
- Company Background Overview: CMCT is a real estate investment trust focused on multifamily and creative office assets in the U.S., leveraging CIM Group's expertise in acquisition and development to strengthen its leadership position in rapidly growing sectors.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CMCT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CMCT
About CMCT
Creative Media & Community Trust Corporation is a real estate investment trust. The Company is a vertically integrated community-focused real estate and infrastructure owner, operator, lender and developer. It primarily acquires, develops, owns, and operates both premier multifamily properties situated in communities throughout the United States and Class A and creative office real assets in markets. Its segments consist of three types of commercial real estate properties, namely office, hotel and multifamily, as well as a segment for the Company’s lending business. The products for the Company’s office segment primarily include rental of office space and other tenant services, including tenant reimbursements, parking, and storage space rental. The products for the Company’s hotel segment include operations of hotel properties. The loan segment includes the sale of the government-guaranteed portion of loans receivable and income from the yield on its loans receivable.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Creative Media & Community Trust to Report Q4 2025 Earnings on March 9, 2026
- Earnings Report Schedule: Creative Media & Community Trust (CMCT) will announce its Q4 2025 earnings results on March 9, 2026, before the market opens, providing insights into the company's financial performance and future outlook.
- Conference Call Details: A conference call is scheduled for 5:00 PM Eastern Time on the same day, hosted by CEO David Thompson and other executives, aimed at discussing financial results and addressing investor questions to enhance transparency.
- Investor Participation Methods: Investors can register and test their connection via the 'Investors' tab on the company website or call in using domestic and international numbers, ensuring broad investor engagement and effective information dissemination.
- Company Background Overview: CMCT is a real estate investment trust focused on multifamily and creative office assets in the U.S., leveraging CIM Group's expertise in acquisition and development to strengthen its leadership position in rapidly growing sectors.
See More
Abbott Laboratories (ABT) Reports Q4 Sales Below Expectations, Stock Drops 7%
- Sales Performance Miss: Abbott Laboratories reported Q4 2025 sales of $11.46 billion, slightly below the consensus estimate of $11.80 billion, with a 4.4% increase in sales but only 3% organic growth, indicating competitive pressure in the market.
- Earnings Outlook Disappointment: Although adjusted earnings per share of $1.50 met Wall Street expectations, the overall performance failed to boost investor confidence, resulting in a stock drop of over 7% on Thursday, reflecting concerns about future growth.
- Market Reaction Intense: Following Abbott's earnings report, the significant stock decline illustrates investor pessimism regarding the company's future performance, which may impact its market position in the MedTech sector.
- Industry Impact Significant: Abbott's disappointing results could trigger a ripple effect across the MedTech industry, prompting investors to reassess the financial health of other related companies, potentially leading to overall valuation fluctuations in the sector.
See More
CMCT Completes $44.9M Sale of Lending Division, Shares Surge 55%
- Stock Surge: CMCT's completion of the sale of its lending division to PG FR Holding, LLC for approximately $44.9 million resulted in a 54.96% increase in share price to $4.5403, indicating strong market confidence in the company's strategic shift.
- Cash Flow Improvement: The transaction yielded about $31.2 million in net cash proceeds after debt payments and transaction costs, significantly enhancing CMCT's liquidity to support its multifamily property investment strategy.
- Strategic Focus: By divesting this division, CMCT has strengthened its balance sheet and improved liquidity, shifting operational emphasis toward multifamily properties to enhance financial stability and long-term growth potential.
- Strong Market Reaction: On the announcement day, CMCT's stock opened lower but experienced heavy buying pressure, with trading volume significantly above average, reflecting investor enthusiasm for the company's renewed focus on core real estate operations.
See More
Procter & Gamble (PG) Stock Rises 2% After Beating EPS Estimates in Mixed Q2 Results
- Market Uptrend: U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points, or 0.63%, reflecting optimistic sentiment towards economic recovery, which may attract more investor interest.
- P&G's Strong Performance: Procter & Gamble reported Q2 adjusted EPS of $1.88, beating the analyst consensus of $1.86, although quarterly sales of $22.208 billion fell short of the expected $22.282 billion, indicating the company's efforts in cost control amidst mixed results.
- Notable Stock Surges: Shares of 60 Degrees Pharmaceuticals skyrocketed 297% to $7.94 after announcing a partnership with Runway Health to expand pre-departure access to ARAKODA, demonstrating strong market reaction to new collaborations.
- Energy Sector Decline: Despite the overall market rise, energy stocks dipped 0.4% on Wednesday, suggesting potential challenges in supply-demand balance within the sector, prompting investors to monitor future market dynamics.
See More
CMCT Declares Preferred Stock Dividends for Q4 2025
- Dividend Declaration: Creative Media & Community Trust Corporation announced the payment of preferred stock dividends for Q4 2025 on January 15, 2026, reflecting the company's ongoing commitment to its shareholders.
- Dividend Amounts: The dividends are set at $0.34375 per share for Series A, $0.426875 for Series A1, and $0.353125 for Series D, indicating the company's efforts in maintaining stable cash flow and shareholder returns.
- Annualized Dividend Rate: The Series A1 preferred stock boasts an annualized dividend rate of 6.83%, which, combined with fluctuations in the federal funds rate, demonstrates the company's financial flexibility and adaptability in the current economic climate.
- Future Outlook: CMCT's Board emphasized plans for future growth, showcasing confidence in long-term strategies despite market volatility and economic uncertainties.
See More
Clearwater Analytics (CWAN) Acquired by Private Equity Consortium for $8.4 Billion
- Acquisition Announcement: A consortium of private equity firms led by Permira and Warburg Pincus has announced a deal to acquire Clearwater Analytics for approximately $8.4 billion, including debt, indicating strong market interest in investment and accounting software companies.
- Stock Price Reaction: Clearwater Analytics shares surged 7.6% to $23.93 in pre-market trading, reflecting positive investor sentiment regarding the acquisition news, which may enhance the company's future market performance.
- Market Impact: This acquisition not only provides Clearwater Analytics with financial backing but also has the potential to accelerate its technological innovation and market expansion, strengthening its position in the highly competitive software industry.
- Industry Trend: With private equity firms continuing to invest in the software sector, more similar transactions are expected, further consolidating market resources and enhancing industry competitiveness.
See More
Creative Media & Community Trust to Report Q4 2025 Earnings on March 9, 2026
- Earnings Report Schedule: Creative Media & Community Trust (CMCT) will announce its Q4 2025 earnings results on March 9, 2026, before the market opens, providing insights into the company's financial performance and future outlook.
- Conference Call Details: A conference call is scheduled for 5:00 PM Eastern Time on the same day, hosted by CEO David Thompson and other executives, aimed at discussing financial results and addressing investor questions to enhance transparency.
- Investor Participation Methods: Investors can register and test their connection via the 'Investors' tab on the company website or call in using domestic and international numbers, ensuring broad investor engagement and effective information dissemination.
- Company Background Overview: CMCT is a real estate investment trust focused on multifamily and creative office assets in the U.S., leveraging CIM Group's expertise in acquisition and development to strengthen its leadership position in rapidly growing sectors.
See More
Abbott Laboratories (ABT) Reports Q4 Sales Below Expectations, Stock Drops 7%
- Sales Performance Miss: Abbott Laboratories reported Q4 2025 sales of $11.46 billion, slightly below the consensus estimate of $11.80 billion, with a 4.4% increase in sales but only 3% organic growth, indicating competitive pressure in the market.
- Earnings Outlook Disappointment: Although adjusted earnings per share of $1.50 met Wall Street expectations, the overall performance failed to boost investor confidence, resulting in a stock drop of over 7% on Thursday, reflecting concerns about future growth.
- Market Reaction Intense: Following Abbott's earnings report, the significant stock decline illustrates investor pessimism regarding the company's future performance, which may impact its market position in the MedTech sector.
- Industry Impact Significant: Abbott's disappointing results could trigger a ripple effect across the MedTech industry, prompting investors to reassess the financial health of other related companies, potentially leading to overall valuation fluctuations in the sector.
See More
CMCT Completes $44.9M Sale of Lending Division, Shares Surge 55%
- Stock Surge: CMCT's completion of the sale of its lending division to PG FR Holding, LLC for approximately $44.9 million resulted in a 54.96% increase in share price to $4.5403, indicating strong market confidence in the company's strategic shift.
- Cash Flow Improvement: The transaction yielded about $31.2 million in net cash proceeds after debt payments and transaction costs, significantly enhancing CMCT's liquidity to support its multifamily property investment strategy.
- Strategic Focus: By divesting this division, CMCT has strengthened its balance sheet and improved liquidity, shifting operational emphasis toward multifamily properties to enhance financial stability and long-term growth potential.
- Strong Market Reaction: On the announcement day, CMCT's stock opened lower but experienced heavy buying pressure, with trading volume significantly above average, reflecting investor enthusiasm for the company's renewed focus on core real estate operations.
See More
Procter & Gamble (PG) Stock Rises 2% After Beating EPS Estimates in Mixed Q2 Results
- Market Uptrend: U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points, or 0.63%, reflecting optimistic sentiment towards economic recovery, which may attract more investor interest.
- P&G's Strong Performance: Procter & Gamble reported Q2 adjusted EPS of $1.88, beating the analyst consensus of $1.86, although quarterly sales of $22.208 billion fell short of the expected $22.282 billion, indicating the company's efforts in cost control amidst mixed results.
- Notable Stock Surges: Shares of 60 Degrees Pharmaceuticals skyrocketed 297% to $7.94 after announcing a partnership with Runway Health to expand pre-departure access to ARAKODA, demonstrating strong market reaction to new collaborations.
- Energy Sector Decline: Despite the overall market rise, energy stocks dipped 0.4% on Wednesday, suggesting potential challenges in supply-demand balance within the sector, prompting investors to monitor future market dynamics.
See More
CMCT Declares Preferred Stock Dividends for Q4 2025
- Dividend Declaration: Creative Media & Community Trust Corporation announced the payment of preferred stock dividends for Q4 2025 on January 15, 2026, reflecting the company's ongoing commitment to its shareholders.
- Dividend Amounts: The dividends are set at $0.34375 per share for Series A, $0.426875 for Series A1, and $0.353125 for Series D, indicating the company's efforts in maintaining stable cash flow and shareholder returns.
- Annualized Dividend Rate: The Series A1 preferred stock boasts an annualized dividend rate of 6.83%, which, combined with fluctuations in the federal funds rate, demonstrates the company's financial flexibility and adaptability in the current economic climate.
- Future Outlook: CMCT's Board emphasized plans for future growth, showcasing confidence in long-term strategies despite market volatility and economic uncertainties.
See More
Clearwater Analytics (CWAN) Acquired by Private Equity Consortium for $8.4 Billion
- Acquisition Announcement: A consortium of private equity firms led by Permira and Warburg Pincus has announced a deal to acquire Clearwater Analytics for approximately $8.4 billion, including debt, indicating strong market interest in investment and accounting software companies.
- Stock Price Reaction: Clearwater Analytics shares surged 7.6% to $23.93 in pre-market trading, reflecting positive investor sentiment regarding the acquisition news, which may enhance the company's future market performance.
- Market Impact: This acquisition not only provides Clearwater Analytics with financial backing but also has the potential to accelerate its technological innovation and market expansion, strengthening its position in the highly competitive software industry.
- Industry Trend: With private equity firms continuing to invest in the software sector, more similar transactions are expected, further consolidating market resources and enhancing industry competitiveness.
See More
